Speculative activity surged across the micro-cap landscape during the third quarter, fueled by thematic momentum and outsized ...

A regenerative medicine company will open a headquarters office in Boca that includes manufacturing and distribution ...

CollaBraid is the first product the company aims to bring to market in 2026. The technology is a hybrid collagen suture — a thread-like material that surgeons use to stitch tissue together — for a ...

Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...

China's Angel Yeast has begun operating an 11,000-tonne production line for its yeast protein, bolstering the country's ...

A recent deep dive into the unraveling of Moderna by reporter Jason Mast is one of the most popular STAT stories of the year.

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Bangkok company's HairFolico venture uses patient's own hair cells for natural regrowth, challenging Turkey's dominance in ...

America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.